TUCSON, Ariz., April 12 /PRNewswire-FirstCall/ -- Ventana Medical Systems,
Inc. (Nasdaq: VMSI), today announced that it will hold a conference call on
Friday, April 19, 2002, at 10:00 a.m. EST to discuss its first-quarter
financial and operating results. The call can be accessed via the Internet
live and as a replay at http://www.vcall.com . The webcast will be available for
replay for a period of 30 days.
Ventana develops, manufactures and markets instrument/reagent systems that
automate tissue preparation and slide staining in clinical histology and drug
discovery laboratories worldwide. Ventana's clinical systems are important
tools used in the diagnosis and treatment of cancer and infectious diseases.
Ventana's drug discovery systems are used to accelerate the discovery of new
drug targets and evaluate the safety of new drug compounds.
For more information on Ventana Medical Systems visit http://www.ventanamed.com .
The Molecular Discovery Systems Division has its own website at
http://www.ventanadiscovery.com .
SOURCE Ventana Medical Systems, Inc.
 back to top
Related links:
http://www.ventanamed.com
http://www.ventanadiscovery.com
CONTACT:
Christopher M. Gleeson, President and CEO,
+1-520-229-3787, or Nick Malden, Chief Financial Officer,
+1-520-229-3857, both of Ventana Medical Systems, Inc.
|
